Recent News

• 02.11.2026 - Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
• 01.12.2026 - Geron Corporation Provides 2026 Financial Guidance
• 12.18.2025 - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 12.11.2025 - Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
• 12.08.2025 - Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS
• 10.13.2025 - Geron Corporation Announces Executive Leadership Transitions and Appointments

Recent Filings

• 01.12.2026 - 8-K Current report
• 01.12.2026 - EX-99.1 EX-99.1
• 01.06.2026 - 8-K Current report
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.16.2025 - 8-K Current report
• 12.15.2025 - 144 Report of proposed sale of securities
• 11.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.05.2025 - 8-K Current report
• 11.05.2025 - EX-99.1 EX-99.1
• 10.20.2025 - 3 Initial statement of beneficial ownership of securities